616 related articles for article (PubMed ID: 12385436)
21. Epidemiology of acute upper gastrointestinal bleeding.
van Leerdam ME
Best Pract Res Clin Gastroenterol; 2008; 22(2):209-24. PubMed ID: 18346679
[TBL] [Abstract][Full Text] [Related]
22. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
23. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
24. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
25. Trends in gastrointestinal bleeding in the Region of Valencia (2000-2005). Relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medication.
Peiró Moreno S; Cervera-Casino P; Sanfélix-Gimeno G; Librero López J
Farm Hosp; 2011; 35(6):289-97. PubMed ID: 21481622
[TBL] [Abstract][Full Text] [Related]
26. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000.
van Leerdam ME; Vreeburg EM; Rauws EA; Geraedts AA; Tijssen JG; Reitsma JB; Tytgat GN
Am J Gastroenterol; 2003 Jul; 98(7):1494-9. PubMed ID: 12873568
[TBL] [Abstract][Full Text] [Related]
27. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study.
Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT
Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569
[TBL] [Abstract][Full Text] [Related]
28. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.
Taha AS; Angerson WJ; Prasad R; McCloskey C; Gilmour D; Morran CG
Aliment Pharmacol Ther; 2008 Oct; 28(7):878-85. PubMed ID: 18644010
[TBL] [Abstract][Full Text] [Related]
29. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
[TBL] [Abstract][Full Text] [Related]
30. Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD
Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205
[TBL] [Abstract][Full Text] [Related]
31. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
32. Exposure to nonsteroidal anti-inflammatory drugs among older adult patients hospitalized for peptic ulcer disease in Argentina: A case-control study.
Insúa J; Mavros P; Hunsche E; Kong S; Tibaudin-Agver O
Am J Geriatr Pharmacother; 2006 Sep; 4(3):251-9. PubMed ID: 17062326
[TBL] [Abstract][Full Text] [Related]
33. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002.
Kang JY; Elders A; Majeed A; Maxwell JD; Bardhan KD
Aliment Pharmacol Ther; 2006 Jul; 24(1):65-79. PubMed ID: 16803604
[TBL] [Abstract][Full Text] [Related]
34. [The duodenum and non-steroidal anti-inflammatory agents].
Pippa G; Apuzzo M; Bazuro ME; Tammaro G
Recenti Prog Med; 1990 Jun; 81(6):453-6. PubMed ID: 2251456
[TBL] [Abstract][Full Text] [Related]
35. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
[TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
Hirschowitz BI
Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
[TBL] [Abstract][Full Text] [Related]
37. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease.
Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ
Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology considerations in peptic ulcer disease.
Schlesinger PK; Robinson B; Layden TJ
J Assoc Acad Minor Phys; 1992; 3(3):70-7. PubMed ID: 1498525
[TBL] [Abstract][Full Text] [Related]
39. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
Arch Intern Med; 1993 Jul; 153(14):1665-70. PubMed ID: 8333804
[TBL] [Abstract][Full Text] [Related]
40. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
